U.S Anticonvulsant Medications: Label and Off-Label Uses


Regular Price: USD 2,450.00

Special Price USD 1,715.00

30% OFF

* Required Fields

Regular Price: USD 2,450.00

Special Price USD 1,715.00


Be the first to review this product

This market study focuses on the U.S. Anticonvulsant Market: Label and Off-label Uses. Information is presented on specific CNS disorders (epilepsy, bipolar, migraine and pain), the current role of anticonvulsants in therapy and the potential future role. Forecasted anticonvulsant revenues are presented for the 2001 to 2005 period.

Table of Contents

U.S Anticonvulsant Medications, Executive SummaryExecutive SummaryExecutive SummaryU.S Anticonvulsant Medications, Introduction and MethodologyIntroductionIntroduction To The U.S. Anticonvulsant MarketStudy ObjectivesMethodologyPrimary And Secondary ResearchFrost And Sullivan's Market Forecasting ModelU.S Anticonvulsant Medications, Total U.S. Anticonvulsant Market OverviewIntroductionFDA-Approved First-Generation AnticonvulsantsFDA-Approved Second-Generation Anticonvulsants: 1993 - 1996FDA-Approved Second-Generation Anticonvulsants: 1997 - 2000Alternative TherapiesU.S. Anticonvulsant Market Performance: 1990 to 2000U.S. Anticonvulsant Market Revenues: 1990 - 2000Second-Generation Anticonvulsant Market Performance: 1997 - 2000Market Engineering AnalysisMarket Engineering AwardsTechnology Innovation AwardProduct Differentiation Innovation AwardProduct Launch Strategy AwardU.S Anticonvulsant Medications, The Epilepsy MarketDisease OverviewIntroductionClinical PresentationDiagnosing And Treating EpilepsyDiagnosis and Seizure ClassificationTolerabilityAge And Medical ConditionHealth Care CoverageEpilepsy Market Potential For Second-Generation AnticonvulsantsEpilepsy Market Share Analysis (2000)First-Generation AnticonvulsantsSecond-Generation AnticonvulsantsMajor Opportunities And ChallengesChallengesMarket DriversMarket RestraintsForecasts and TrendsDemand AnalysisPricing TrendsMarket And Technology TrendsFirst-Generation Anticonvulsant Revenues: Assumptions And ForecastsSecond-Generation Anticonvulsant Revenues: Assumptions And ForecastsStrategic RecommendationsStrategies OverviewStrategic Recommendations For Market Challenge 1Strategic Recommendations For Market Challenge 2Strategic Recommendations For Market Challenge 3Strategic Recommendations For Market Challenge 4U.S Anticonvulsant Medications, The U.S. Bipolar Disorder MarketDisease OverviewEpidemiology And EtiologyClinical PresentationDiagnosing And Treating Bipolar DisorderDiagnosing Bipolar DisorderGoals Of Treatment and Therapeutic OptionsBipolar Market Potential For Second-Generation AnticonvulsantsBipolar Market Share Analysis (2000)Front-Line Therapies: Mood StabilizersSecond-Line Therapies: Second-Generation Anticonvulsants Vs. Atypical AntipsychoticsMajor Opportunities and ChallengesChallengesMarket DriversMarket RestraintsForecast And Trends Market And Technology TrendsRevenue ForecastsStrategic RecommendationsStrategies OverviewStrategic Recommendations For Market Challenge 1Strategic Recommendations For Market Challenge 2U.S Anticonvulsant Medications, Other Off-Label MarketsPain MarketsOverview Treatment Options and Market PotentialMigraine Prophalaxis MarketsOverview and Treatment OptionsThe Migraine Prophylaxis Market Potential For Anticonvulsants

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.